MAP2K7 and gastric cancer: As the MEK/ERK pathway plays a critical role in PAK4-induced cell proliferation [17], we subsequently explore whether the MEK/ERK pathway was involved in miR-199a/b-3p antitumor effect by targeting PAK4 in GC.